More Anatara Lifesciences Ltd news
Anatara Lifesciences LtdASX: ANR

Response to ASX Appendix 4C Query

Feb 19, 2019 at 10:47 PM EST · Issued by Anatara Lifesciences Ltd

Filed with ASX · Feb 19, 2019 at 10:47 PM EST

On 6ix: 6ix.com/news/response-to-asx-appendix-4c-query-59

Anatara Lifesciences Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Anatara Lifesciences Ltd on 6ix

In the deck

  • Anatara Lifesciences — Proactive Investors Australia CEO Sessions and Wholesale Investor's Emergence 201916 slidesFeb 19, 2019

Earlier from Anatara Lifesciences

  • Successful proof of concept studiesFeb 7, 2019
  • R&D Tax Refund ReceivedJan 13, 2019
  • Chief Executive Officer AppointmentNov 13, 2018
  • APVMA approval for DetachOct 28, 2018
  • Appendix 4E & Audited Financial StatementsAug 31, 2018

Later from Anatara Lifesciences

  • Anatara retains global market for DetachJun 13, 2019
  • Anatara Animal Health Asset UpdateJun 28, 2019
  • Anatara Animal Health Assets UpdateAug 4, 2019
  • Appendix 4E and Financial ReportAug 27, 2019
  • Anatara reports statistically significant animal studiesOct 13, 2019
All Anatara Lifesciences news releases↗

Follow Anatara Lifesciences into a list and get an email when it puts out news.

Follow Anatara Lifesciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer